NGNE logo

Neurogene Inc.

NGNE
Healthcare|Biotechnology|US
$25.31
-0.34 (-1.33%)
DCF Value
$4.36
Tangible Book / Share
$9.63
Cash / Share
$9.99
Next Earnings Report
Nov 12, 2026
EPS est. -$1.49
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Jul 2, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (2)

Nov 2028
Est. completion
P1P2Neuronal Ceroid Lipofuscinosis CLN5
Gene Therapy Study for Children With CLN5 Batten Disease
NCT05228145n=6
Dec 2029
Est. completion
P3Rett Syndrome
A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett Syndrome
NCT05898620n=33

Recent Press Releases

Neurogene Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Nov 5, 2026 · Business Wire
Neurogene to Participate in Upcoming Investor Conferences
Nov 3, 2026 · Business Wire
Neurogene Presents New Data at ESGCT Congress that Reinforce Key Differentiators of NGN-401 Gene Therapy for Rett Syndrome
Oct 27, 2026 · Business Wire
Neurogene Announces Upcoming Presentations Highlighting Key Differentiators of NGN-401 for Rett Syndrome at the ESGCT 33rd Annual Congress
Oct 20, 2026 · Business Wire
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 5, 2026 · Business Wire
Neurogene to Participate in H.C. Wainwright 28th Annual Global Investment Conference
Sep 8, 2026 · Business Wire
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 4, 2026 · Business Wire
Neurogene Reports Second Quarter 2026 Financial Results and Highlights Recent Updates
Aug 11, 2026 · Business Wire

SEC Filings (78)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 7, 2026SC 13GPassive 5%+ stakeDocumentIndex
Oct 6, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 11, 202610-QQuarterly reportDocumentIndex
Aug 11, 20268-KMaterial eventDocumentIndex
Jul 2, 20268-KMaterial eventDocumentIndex
Jul 2, 2026424B5Offering prospectusDocumentIndex
Jun 30, 2026424B5Offering prospectusDocumentIndex
Jun 29, 20268-KMaterial eventDocumentIndex
Jun 8, 20268-KMaterial eventDocumentIndex
Jun 4, 20268-KMaterial eventDocumentIndex
May 12, 20268-KMaterial eventDocumentIndex
May 12, 202610-QQuarterly reportDocumentIndex
Apr 20, 20268-KMaterial eventDocumentIndex
Apr 16, 2026ARSAnnual report to holdersDocumentIndex
Apr 16, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 16, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 24, 2026S-8Employee stock planDocumentIndex
Mar 24, 202610-KAnnual reportDocumentIndex
Mar 24, 20268-KMaterial eventDocumentIndex
Feb 26, 20268-KMaterial eventDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jan 12, 20268-KMaterial eventDocumentIndex
Dec 15, 2025SC 13GPassive 5%+ stakeDocumentIndex
Nov 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 13, 20258-KMaterial eventDocumentIndex
Nov 13, 202510-QQuarterly reportDocumentIndex
Nov 12, 20258-KMaterial eventDocumentIndex
Nov 6, 20258-KMaterial eventDocumentIndex
Oct 9, 20258-KMaterial eventDocumentIndex
Aug 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Aug 11, 2025424B5Offering prospectusDocumentIndex
Aug 11, 20258-KMaterial eventDocumentIndex
Aug 11, 202510-QQuarterly reportDocumentIndex
Jun 30, 20258-KMaterial eventDocumentIndex
Jun 12, 20258-KMaterial eventDocumentIndex
Jun 9, 20258-KMaterial eventDocumentIndex